What development phase is Abiocine in?

Abiocine is FDA-approved (marketed).

What is the generic name of Abiocine?

DIHYDROSTREPTOMYCIN is the generic (nonproprietary) name of Abiocine.

Last reviewed 2026-04-20 · How we verify

Abiocine (DIHYDROSTREPTOMYCIN)

FDA-approved withdrawn Small molecule Quality 6/100

At a glance

Generic name	DIHYDROSTREPTOMYCIN
Drug class	dihydrostreptomycin
Modality	Small molecule
Therapeutic area	Infectious Disease
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Abiocine CI brief — competitive landscape report
Abiocine updates RSS · CI watch RSS